Citations

PREMIR Page References
‍

1. How Common Is Breast Cancer?: Breast Cancer Statistics. (n.d.). Retrieved from https://www.cancer.org/cancer/breast-cancer/about/how-common-is-breast-cancer.html
2. Kerlikowske K;Zhu W;Hubbard RA;Geller B;Dittus K;Braithwaite D;Wernli KJ;Miglioretti DL;O'Meara ES; ;. (n.d.). Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy. Retrieved from https://pubmed.ncbi.nlm.nih.gov/23552817/
3. Jacobi, C. E., Jonker, M. A., Nagelkerke, N. J., Houwelingen, J. C., & Bock, G. H. (2003, July 01). Prevalence of family histories of breast cancer in the general population and the incidence of related seeking of health care. Retrieved from https://jmg.bmj.com/content/40/7/e83
4. Key facts and figures. (2020). doi:10.1787/a900334c-en https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/breast-cancer-facts-and-figures/breast-cancer-facts-and-figures-2019-2020.pdf
5. FJ;, L. J. (n.d.). Common Genetic Variation and Breast Cancer Risk-Past, Present, and Future. Retrieved from https://pubmed.ncbi.nlm.nih.gov/29382703/
6. Breast Cancer Risk Factors: Family History. (2021, April 21). Retrieved from https://www.breastcancer.org/risk/factors/family_history
7. DeSantis, C. E., Ma, J., Gaudet, M. M., Newman, L. A., Miller, K. D., Sauer, A. G., . . . Siegel, R. L. (2019, October 02). Breast cancer statistics, 2019. Retrieved from https://acsjournals.onlinelibrary.wiley.com/doi/10.3322/caac.21583
8. Breast Cancer Risk in American Women. (n.d.). Retrieved from https://www.cancer.gov/types/breast/risk-fact-sheet
9. What Does It Mean to Have Dense Breasts? (2020, January 14). Retrieved from https://www.cdc.gov/cancer/breast/basic_info/dense-breasts.htm
10. P;, N. S. (n.d.). An overview of mammographic density and its association with breast cancer. Retrieved from https://pubmed.ncbi.nlm.nih.gov/29651637/
11. Hereditary Breast Cancer and BRCA Genes. (2019, April 05). Retrieved from https://www.cdc.gov/cancer/breast/young_women/bringyourbrave/hereditary_breast_cancer/index.htm
12. BRCA Gene Mutations: Cancer Risk and Genetic Testing Fact Sheet. (n.d.). Retrieved from https://www.cancer.gov/about-cancer/causes-prevention/genetics/brca-fact-sheet
13. Mehrgou, A., & Akouchekian, M. (2016, May 15). The importance of BRCA1 and BRCA2 genes mutations in breast cancer development. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972064/#:~:text=Hereditary breast cancer, which is,15% of ovarian cancer cases.
14. Daly, M. B., Pilarski, R., Yurgelun, M. B., Berry, M. P., Buys, S. S., Dickson, P., . . . Darlow, S. D. (2020, April 01). NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020. Retrieved from https://jnccn.org/view/journals/jnccn/18/4/article-p380.xml
15. Hyperplasia of the Breast (Ductal or Lobular). (n.d.). Retrieved from https://www.cancer.org/cancer/breast-cancer/non-cancerous-breast-conditions/hyperplasia-of-the-breast-ductal-or-lobular.html
16. Ductal Carcinoma In Situ: Symptoms, Diagnosis, and Treatment. (2019, March 09). Retrieved from https://www.breastcancer.org/symptoms/types/dcis
17. Kerlikowske, K. (2010). Epidemiology of ductal carcinoma in situ. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5161058/#:~:text=Because it is rarely clinically,cases (2–4).
18. Diagnosis of DCIS. (2018, February 20). Retrieved from https://www.breastcancer.org/symptoms/types/dcis/diagnosis
19. Lobular Carcinoma In Situ (LCIS). (2019, March 09). Retrieved from https://www.breastcancer.org/symptoms/types/lcis
20. LCIS and Breast Cancer Risk. (2016, February 18). Retrieved from https://www.breastcancer.org/symptoms/types/lcis/cancer_risk#:~:text=One estimate is that the,over the next 15 years.
21. Symptoms and Diagnosis of LCIS. (2015, September 30). Retrieved from https://www.breastcancer.org/symptoms/types/lcis/symptoms_diagnosis
22. King, T. A., Pilewskie, M., Muhsen, S., Patil, S., Mautner, S. K., Park, A., . . . Morrow, M. (n.d.). Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer Risk. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4934644/
    

Technology Page References
‍

1. Kosaka, N., Yoshioka, Y., Fujita, Y., & Ochiya, T. (2016, April 01). Versatile roles of extracellular vesicles in cancer. Retrieved from https://www.jci.org/articles/view/81130
2. Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., . . . Golub, T. R. (n.d.). MicroRNA expression profiles classify human cancers. Retrieved from https://www.nature.com/articles/nature03702
3. Calin, G. A., & Croce, C. M. (n.d.). MicroRNA signatures in human cancers. Retrieved from https://www.nature.com/articles/nrc1997
4. Galvão-Lima, L. J., Morais, A. H., Valentim, R. A., & Barreto, E. J. (2021, February 16). MiRNAs as biomarkers for early cancer detection and their application in the development of new diagnostic tools. Retrieved from https://biomedical-engineering-online.biomedcentral.com/articles/10.1186/s12938-021-00857-9
5. Jang, J. Y., Kim, Y. S., Kang, K. N., Kim, K. H., Park, Y. J., & Kim, C. W. (2021, February). Multiple microRNAs as biomarkers for early breast cancer diagnosis. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783718/
6. PubMed_((miRNA) OR (micro RNA)) AND ((cancer) OR (tumor)) AND ((early stage) OR (early-stage))_2000_2020
7. PubMed_((cfDNA) OR (cell-free DNA)) AND ((cancer) OR (tumor)) AND ((early stage) OR (early-stage))_2000_2020
8. Gahlawat, A. W., Lenhardt, J., Witte, T., Keitel, D., Kaufhold, A., Maass, K. K., . . . Schott, S. (2019). Evaluation of Storage Tubes for Combined Analysis of Circulating Nucleic Acids in Liquid Biopsies. International Journal of Molecular Sciences, 20(3), 704. doi:10.3390/ijms20030704
9. Mafi, M. (2018). Review of "Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies". doi:10.14322/publons.r2313482
10. Volik, S., Alcaide, M., Morin, R. D., & Collins, C. (2016). Cell-free DNA (cfDNA): Clinical Significance and Utility in Cancer Shaped By Emerging Technologies. Molecular Cancer Research, 14(10), 898-908. doi:10.1158/1541-7786.mcr-16-0044

‍